1-1 of 1 results for subject:Pfizer
Librarians' tools
- Search time
- 0.299 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Pfizer
- We searched for
- subject_t:Pfizer OR subject_ses:61578
Answering member
X
Lord Warner
Type
House
Session
Year
Department
Member
Primary member
Answering member
More
Warner, Lord (1)
Legislative stage
Legislation
Subject
Publisher
asked Her Majesty's Government:What representations they have received on the consequences for patients of Pfizer's decision, as the major supplier of medicines to the National Health Service, that from 5 March 2007 all its products will be distributed into the United Kingdom medical supply chain by one logistics service provider;...
asked Her Majesty's Government:What representations they have received on the consequences for patients of Pfizer's decision, as the major supplier of medicines to the National Health Service, that from 5 March 2007 all its products will be distributed into the United Kingdom medical supply chain by one logistics service provider;...
Asked by
Lord Morris of Manchester
(Labour)
Answered by
Lord Warner
(Labour)
Type
Written questions
Status
Answered
Answered on
4 December 2006
Since the announcement by Pfizer on 28 September 2006 of future changes to the distribution arrangements for its drugs, the department has received approximately 460 written representations concerned with this issue. Of these, 71 were from honourable Members and the remainder from pharmacists, wholesalers and the public. Additionally, there have been 10 House of Commons Parliamentary Questions on the issue. The department will monitor these new arrangements with a view to taking corrective action if appropriate.
Subjects
Drugs; Distribution; NHS; Procurement; Pfizer
Date
4 December 2006
Reference
174; 687 c96WA
House
House of Lords